Gene Falkowski, DO
Orthopaedic Surgery of the Spine · Anchorage, AKNPI 1841554201
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.3%), food and beverage and education — rather than concentrated in one kind of arrangement. Globus Medical accounts for 77.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $4,517 and has fallen 95.1% since, to $219 in 2025.
Across 54 payments — averaging $95.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$4K
- Medtronic$565
- Si-bone, Inc.$141
- Nuvasive Specialized Orthopedics, Inc.$106
- Cerapedics Inc.$99
- Johnson & Johnson$63
- plus $204 from 7 others
Across 2 payments — averaging $75,000 each. An ownership or investment interest held by the physician or an immediate family member.
- Durastat LLC$150K
What the payments were for
- Travel & lodging$2,85155%
- Food & beverage$2,20843%
- Education$992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 34 | $3,980 |
| Medtronic | 6 | $565 |
| Si-bone, Inc. | 2 | $141 |
| Nuvasive Specialized Orthopedics, Inc. | 1 | $106 |
| Cerapedics Inc. | 1 | $99 |
| Johnson & Johnson | 2 | $63 |
| Icotec Medical Inc. | 1 | $56 |
| Bioventus LLC | 2 | $40 |
| Augmedics Inc. | 1 | $31 |
| Stryker | 1 | $23 |
| Axogen | 1 | $21 |
| Abbott | 1 | $21 |
| Pacira Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XLIF$1,339
- ALIF$1,062
- DIVERGENCE-L$516
- Osteocel$321
- Pulse$183
- CoRoent$159
- PRECICE Intramedullary Limb Lengthening System$106
How this compares
Too few orthopaedic surgery of the spine providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 67 | $825 |
| Methocarbamol | 27 | $163 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $153 |
| Meloxicam | 26 | $131 |
| Ondansetron OdtOndansetron | 14 | $108 |
| Cyclobenzaprine Hcl | 14 | $79 |
| Tramadol Hcl | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Anchorage
- Iain ElliottAnchorage$30K
- James EuleAnchorage$17K
- Derrick FogeAnchorage$7K
- Upshur SpencerAnchorage$4K
- Mark FlanumAnchorage$3K
- Curtis MinaAnchorage$3K
- Davis PetersonAnchorage$272
- Steven HumphreysSoldotna$199K
- Stewart KerrFairbanks$51K
- John AndreshakSoldotna$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.